Ameritox invests in depression blood test with Ridge licensing deal
This article was originally published in Clinica
Executive Summary
Pain medication monitoring specialist Ameritox is branching out into depression after signing a deal that will allow it to sell Ridge Diagnostics' blood test for major depressive disorder, MDDScore, to primary care and pain physicians. Ridge claims the product is the first clinically-available blood test for depression – albeit to a very limited market for now – and CEO Lonna Williams told Clinica the company hasn't "seen anything else on the horizon".